The story of Viagra presents a challenging picture for shareholders. While the initial release generated significant profits, the lapse of its intellectual property protection opened the floodgates to cheaper https://social-lyft.com/story11740222/sildenafil-and-the-pharmaceutical-industry-a-precarious-bet